Fang-Tsyr Lin, MD, PhD

FangTsyrLin
Institution: University of Alabama at Birmingham
Category: Understanding resistance: Improving effectiveness

Fang-Tsyr Lin, MD, PhD
University of Alabama at Birmingham

Role of TRIP6 in Ovarian Cancer Progression

TRIP6 is a novel molecule that helps make cancer cells immortal, thus allowing cancer to grow uncontrolled. This study will determine if silencing TRIP6 can increase the effectiveness of chemotherapy.

The Rivkin Center Joins OCRA

Starting April 1, 2025, the Rivkin Center’s ovarian cancer research funding, global symposium and fundraising activities will continue under the leadership of Ovarian Cancer Research Alliance (OCRA).

Melissa Saul